1. Meige disease: striatal dopaminergic preponderance;Tolosa, E.S.; Lai, C.;Neurology,1979
2. and neurotransmitter mechanisms in the dystonias;Stahl, S.M.; Bromocriptine, Berger P.A.; physostigmine;Neurology
3. Neuropharmacological profile of Meige's disease: overview and a case report;Ortiz, A.;Clin Neuropharmac-ol,1983
4. Pharmacology of cranial dystonia;Marsden, C.D.; Lang, A.E.; Sheehy, M.P.;Neurology,1983
5. Cerebrospinal fluid GABA in neurological disease. Neurologs';Neophytides, A.; Suria, A.; Chase, T.N.,1978